| Carissia Gilmer, PHARMD | |
|
1410 S 4th St, Nashville, AR 71852-3009 | |
| (870) 845-1413 | |
| Not Available |
| Full Name | Carissia Gilmer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1410 S 4th St, Nashville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750384210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 08637 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carissia Gilmer, PHARMD 3648 Highway 301 S, Delight, AR 71940-8068 Ph: () - | Carissia Gilmer, PHARMD 1410 S 4th St, Nashville, AR 71852-3009 Ph: (870) 845-1413 |
News Archive
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
Despite the existence of effective programs for treating alcohol dependencies and disorders, less than a quarter of people who are diagnosed actually seek treatment. In a recent study by Columbia University's Mailman School of Public Health researchers report that people diagnosed with alcoholism at some point in their lifetime were more than 60% less likely to seek treatment if they believed they would be stigmatized once their status is known.
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of major depressive disorder.
› Verified 2 days ago
Zachary Tyler Tollett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 S Main St, Nashville, AR 71852 Phone: 870-912-0858 | |
James Michael Haynie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 614 S Main St, Nashville, AR 71852 Phone: 870-845-4277 Fax: 870-845-5984 | |
Dr. Hayden Brooke Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 S Bingen Cir, Nashville, AR 71852 Phone: 870-200-2221 | |
Jodi Troutt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1703 Mount Pleasant Dr, Nashville, AR 71852 Phone: 870-200-0658 | |
Jacquelyn J Howard, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1310 S 4th St, Nashville, AR 71852 Phone: 870-845-1413 | |
Rachel Foshee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1310 S 4th St, Nashville, AR 71852 Phone: 870-845-1413 Fax: 870-845-2403 | |
Dr. Karon Dale Baxley, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 Montgomery St, Nashville, AR 71852 Phone: 870-451-3683 |